Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Oryzon Genomics SA (ORN.MU)

2.5400
+0.1600
+(6.72%)
As of 8:03:39 AM GMT+2. Market Open.
Loading Chart for ORN.MU
  • Previous Close 2.3800
  • Open 2.5400
  • Bid 2.7300 x --
  • Ask 2.8050 x --
  • Day's Range 2.5400 - 2.5400
  • 52 Week Range 1.4200 - 3.7400
  • Volume 0
  • Avg. Volume 42
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: ORN.MU

View More

Performance Overview: ORN.MU

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .

YTD Return

ORN.MU
67.55%
IBEX 35... (^IBEX)
14.24%

1-Year Return

ORN.MU
25.43%
IBEX 35... (^IBEX)
19.51%

3-Year Return

ORN.MU
1.17%
IBEX 35... (^IBEX)
52.33%

5-Year Return

ORN.MU
28.85%
IBEX 35... (^IBEX)
99.27%

Compare To: ORN.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ORN.MU

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    201.90M

  • Enterprise Value

    205.20M

  • Trailing P/E

    --

  • Forward P/E

    13.66

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.59

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    246.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ORN.MU

View More

Company Insights: ORN.MU

Research Reports: ORN.MU

View More